Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata
We are so excited to announce that yesterday the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for
Understanding the Risks of JAK Inhibitors
For several years now Janus Kinase (JAK) inhibitors have been the latest breakthrough in Alopecia Areata treatment. Rather than suppressing
iRest Yoga Nidra Thursdays with Jen Baradi
Join Jen for her free Zoom webinars scheduled every Thursday at 1:00 pm ET. These sessions run about 45 minutes and involve chair yoga
Epigallocatechin-3 Gallate as a Potential Alternative to JAK Inhibitors?
Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients For several years, the big breakthrough in Alopecia Areata
Jennifer Krahn Presents: Living Life with Freedom
Join us July 12th at 2 pm ET for a presentation and eyebrow tutorial by Jennifer Krahn, the Freedom Wig representative
Dr. Donovan Alopecia 2020 Presentation (Link to Recording)
This past Saturday CANAAF was delighted to host a presentation and Q&A with Dr. Jeffrey Donovan, a US and Canadian